MedTrace Logo

Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention

NCT00164008 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2013-12-05

No results posted yet for this study

Summary

The purpose of this trial is to see whether zoledronic acid is better than pamidronate to treat low bone density in heart and lung transplant patients.

Conditions

  • Osteopenia
  • Complications of Heart-lung Transplant
  • Other Complications of Lung Transplant

Interventions

DRUG

zoledronic acid vs pamidronate

Sponsors & Collaborators

  • Novartis

    collaborator INDUSTRY

  • Bayside Health

    lead OTHER_GOV

Principal Investigators

  • Duncan J Topliss, MD · The Alfred

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-10-31
Primary Completion
2005-12-31
Completion
2005-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00164008 on ClinicalTrials.gov